510(k) Report

510(k) · Cleared

Cleared

Fortagen Oral Membrane

K071555510(k) TraditionalCleared Aug 30, 200784-day reviewClass II21 CFR 872.3930

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Organogenesis, Inc. · NPL Barrier, Animal Source, Intraoral

Cleared on Aug 30, 2007 as substantially equivalent to K021105 (Organogenesis, Inc., 2002) and 2 other predicates after an 84-day review. Its family tree reaches back 4 generations to 1992. 1 later device descends from it.

Decided
Aug 30, 2007
Review
84 days
Class
Class II
Product code
NPL
Recalls
None
Predicates
3

Its longest line of descent runs back 4 generations to K921895 (1992). 13 ancestors in all, the oldest K830889 (1983). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2006: 1 other ancestor2005: 1 other ancestor2004: 1 other ancestor1997: 2 other ancestors1999: 1 other ancestor1992: 1 other ancestor1983: 1 other ancestor1995: 1 other ancestor2011: 1 descendant clearedK921895 · Tissue Patch, Tissue Graft · Bio-Vascular, Inc. · 1992K961810 · Supple Peri-Guard Pericardium · Bio-Vascular, Inc. · 1996K980431 · Surgisis · Cook Biotech, Inc. · 1998K021105 · Fortaflex Surgical Mesh · Organogenesis, Inc. · 200219801990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 3 other ancestors3 generations back: 3 other ancestors4 generations back: 1 other ancestor 1 generation forward: 1 descendant K021105 · Fortaflex Surgical Mesh · Organogenesis, Inc. · 2002K980431 · Surgisis · Cook Biotech, Inc. · 1998K961810 · Supple Peri-Guard Pericardium · Bio-Vascular, Inc. · 1996K921895 · Tissue Patch, Tissue Graft · Bio-Vascular, Inc. · 19920
  1. Root · 4 generations backK921895 Tissue Patch, Tissue GraftBio-Vascular, Inc. · 1992
  2. 3 generations backK961810 Supple Peri-Guard PericardiumBio-Vascular, Inc. · 1996
  3. 2 generations backK980431 SurgisisCook Biotech, Inc. · 1998
  4. 1 generation backK021105 Fortaflex Surgical MeshOrganogenesis, Inc. · 2002
  5. This deviceK071555 Fortagen Oral MembraneOrganogenesis, Inc. · 2007
  6. Descendant · cites it directly · 0 of its ownK102307 Genoss Collagen Membrane Model GCM1020, GCM3040 Total 6 ModelsGenoss Co., Ltd. · 2011

Most influential descendants

Showing 1 of 1 · See all
  • K102307Genoss Collagen Membrane Model GCM1020, GCM3040 Total 6 ModelsGenoss Co., Ltd. · 2011 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K921895Tissue Patch, Tissue GraftBio-Vascular, Inc.1992—
−3K961810Supple Peri-Guard PericardiumBio-Vascular, Inc.1996—
−2K980431SurgisisCook Biotech, Inc.1998—
−1K021105Fortaflex Surgical MeshOrganogenesis, Inc.2002—
0 (this device)K071555Fortagen Oral MembraneOrganogenesis, Inc.2007—
+1K102307Genoss Collagen Membrane Model GCM1020, GCM3040 Total 6 ModelsGenoss Co., Ltd.2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198310
199210
199510
199720
199910
200410
200510
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
FIG. 1 — Lineage of K071555, 1992–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NPL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NPL device

  1. #1 K212463 Geistlich Bio-Gide, Geistlich Bio-Gide Shape…score 14.5 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K021105Fortaflex Surgical Mesh
Summary page 1
…-based surgical mesh devices and collagen dental membranes previously cleared for commercial distribution. The relevant predicate devices include FortaGen Surgical Mesh (K021105), formerly FortaFlex Surgical Mesh, manufactured by Organogenesis Inc., Ossix-Plus (K053260) manufactured by Colbar LifeScience,…
Organogenesis, Inc.2002—
*K053260Ossix -Plus
Summary page 1
…distribution. The relevant predicate devices include FortaGen Surgical Mesh (K021105), formerly FortaFlex Surgical Mesh, manufactured by Organogenesis Inc., Ossix-Plus (K053260) manufactured by Colbar LifeScience, Ltd., and Bio-Gide Resorbable Bilayer Membrane (K050446) manufactured by Ed. Geistlich Soehn…
Colbar Lifescience, Ltd.2006—
*K050446Bio-Gide Resorbable Bilayer Membrane for Guided Tissue and Bone
Summary page 1
…rly FortaFlex Surgical Mesh, manufactured by Organogenesis Inc., Ossix-Plus (K053260) manufactured by Colbar LifeScience, Ltd., and Bio-Gide Resorbable Bilayer Membrane (K050446) manufactured by Ed. Geistlich Soehne Ag fuir Chemische Industrie. Intended Use: FortaGen Oral Membrane is intended to be used d…
Ed. Geistlich Soehne AG Fuer Chemische Industrie2005—

Also cleared against K021105: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K102307Genoss Collagen Membrane Model GCM1020, GCM3040 Total 6 ModelsGenoss Co., Ltd.20110

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 15 years and passes through 3 companies; a new generation was cleared every 4.0 years on median.
  • 2 of the 13 ancestors have a recall of any class.
  • Of its descendants, K102307 (Genoss Co., Ltd., 2011) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K021105.

How does its category compare?

All NPL devices

NPL Barrier, Animal Source, Intraoral: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · NPL

5in 2025

2007: 12008: 42009: 32010: 22011: 42013: 22014: 52015: 12016: 32017: 32018: 12019: 12020: 22021: 22022: 32023: 22024: 32025: 5
2007high 5 (2014) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NPL

132in 2025

2008: 172 days median2009: 193 days median2011: 286 days median2014: 140 days median2016: 184 days median2017: 200 days median2022: 290 days median2024: 263 days median2025: 132 days median
2007high 290 (2022) · low 132 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NPL

6in 2019

2012: 32019: 6
2007high 6 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NPL

39in 2025

2012: 32013: 22014: 32015: 52016: 92017: 182018: 142019: 222020: 82021: 112022: 192023: 52024: 202025: 39
2007high 39 (2025) · low 0 (2007)2025

MAUDE reports naming product code NPL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
2008417200
2009319300
20102—00
2011428600
20120—33
20132—02
2014514003
20151—05
2016318409
20173200018
20181—014
20191—622
20202—08
20212—011
20223290019
20232—05
20243263020
20255132039
20260—0—

What is it indicated for?

FortaGen Oral Membrane is intended to be used during guided bone and guided tissue regeneration procedures as a biodegradable barrier membrane for: • Ridge augmentation for later implant insertions; • Simultaneous ridge augmentation and implant insertions; • Ridge augmentation around implants inserted in delayed extraction sites; • Ridge augmentation around implants inserted in immediate extraction sites; • Alveolar ridge preservation consequent to tooth…

Read the full statement (123 words)

FortaGen Oral Membrane is intended to be used during guided bone and guided tissue regeneration procedures as a biodegradable barrier membrane for:

• Ridge augmentation for later implant insertions;

• Simultaneous ridge augmentation and implant insertions;

• Ridge augmentation around implants inserted in delayed extraction sites;

• Ridge augmentation around implants inserted in immediate extraction sites;

• Alveolar ridge preservation consequent to tooth (teeth) extraction(s);

• Over the window in lateral window sinus elevation procedures;

• In implants with vertical bone loss due to infection, only in cases where satisfactory debridement and implant surface disinfection can be achieved;

• In intra bony defects around teeth;

• For treatment of recession defects, together with coronally positioned flap;

• In furcation defects in multi-rooted teeth.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K071555: Fortagen Oral Membrane.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K071555

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026